Clinical Trials Update: Jan. 30, 2008
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
339005
A U.S. advisory panel on Friday will review data on an experimental drug that is injected into the eye to stop vision loss in elderly patients at risk of going blind.
273621
Pfizer Inc&#39;s experimental oral  biotechnology drug axitinib demonstrated substantial anti-tumor  activity in patients with advanced thyroid cancer in a small,  mid-stage clinical trial, according to data released at a major  cancer meeting on Saturday.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
17491
A report to be released on Friday  finds the U.S. Food and Drug Administration does very little to  ensure the safety of patients who help test drugs in clinical  trials, The New York Times reports.
671952
THURSDAY, Jan. 27 (HealthDayNews) -- The results of a multi-center trial involving a quartet of drugs may bring fresh hope to patients battling advanced colorectal cancer, researchers reported Thursday.
189691
Elson So, MD, of the Mayo Clinic in Rochester, Minn., and colleagues report their findings in the Nov. 9 issue of the journal Neurology.
668672
MONDAY, Feb. 26 (HealthDay News) -- Breast cancer treatment trials that are funded by drug companies are more likely to show positive results than studies sponsored by other sources, new research suggests.
121268
EPIX initiates a safety trial and gets good efficacy data.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
749165
New studies shed some light on these controversial heart treatments, but many questions remain. What patients need to know.
4785
The risk of treatment-related or toxic death for US cancer patients enrolled in phase 1 clinical drug trials has decreased during the past 12 years.
766518
A study shows promising results for Novartis's COX-2 inhibitor.
527274
roundup Plus: PMC-Sierra lowers forecast...WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations.
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.